Tissue dipeptidyl peptidase iv and adenosine deaminase activities in benign prostatic hypertrophy and prostate cancer

Cancer Research, Therapy and Control

Volumn 11, Issue 2, 2001, Pages 107-111

  Elgün, Serenay ^a   Keskinege, Aytaç ^a   Yilmaz, Erdal ^b  

^a ANKARA UNIVERSITY   (Turkey)

^b Department of Urology ^*  (Turkey)

Author keywords

Adenosine deaminase; Dipeptidyl peptidase IV; Prostate cancer

Indexed keywords

ADENOSINE DEAMINASE; DIPEPTIDYL PEPTIDASE IV;

ADULT; AGED; ARTICLE; CANCER STAGING; CONTROLLED STUDY; CORRELATION FUNCTION; ENZYME ACTIVITY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATE HYPERTROPHY;

EID: 0034963306     PISSN: 10640525     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Arienti G, Polci A, Carlini E, Palmerini CA. Transfer of CD26/dipeptidyl peptidase IV (E.G. 3.5.4.4.) from prostasomes to sperm. FEBS Lett 1997; 410: 343-346.
2. Bogenrieder T, Finstad CL, Freeman RH, Papandreou CN, Scher HI, Albino AP, Reuter VE et al. Expression and localization of aminopeptidase A, aminopeptidase N, and dipeptidyl peptidase IV in benign and malignant human prostate tissue. The Prostate 1997; 33: 225-232.
3. Centelles JJ, Franco R, Bozal J. Distribution of adenosine deaminase in some rat tissues: inhibition by ethanol and dimethylsulfoxide. Comp Biochem Physiol 1987; 86B: 95-98.
4. Ciruela F, Saura C, Canela EI, Mallol J, Lluis C, Franco R. Adenosine deaminase affects ligand-induced signalling by interacting with cell surface adenosine receptors. FEBS Lett 1996; 19: 219-223.
5. De Meester I, Vanhoof G, Lambeir AM, Scharpe S. Use of immobilized adenosine deaminase (EC 3.5.4.4.) for the rapid purification of native human CD26/dipeptidyl peptidase IV (EC 3.4.14.5.). J Immunol Methods 1996; 189: 99-105.
6. Dinjens WN, Ten Kate J, Kirch JA, Tanke HJ, van der Linden EP, van den Ingh HF, van Steenbrugge GJ et al. Adenosine deaminase complexing protein (ADCP) expression and metastatic potential in prostatic adenocarcinomas. J Pathol 1990; 160: 195-201.
7. Dinjens WNM, Ten Kate J, van der Linden EPM, Th. Wijnen J, Khan PM. Bosnian FT. Distribution of adenosine deaminase complexing protein (ADCP) in human tissues. J Histochem Cytochem 1989; 37: 1869-1875.
8. Dong R-P, Kameoka J, Hegen M, Tanaka T, Xu Y, Schlossman SF, Morimoto C. Characterization of adenosine deaminase binding human CD26 on T cells and its biologic role in immune response. J Immunol 1996; 156: 1349-1355.
9. Donofrio J, Coleman MS, Hutton JJ, Daoud A, Lampkin B, Dyminski J. Overproduction of adenine nucleotides and deoxynucleotides in adenosine deaminase deficiency with severe combined immunodeficiency disease. J Clin Invest 1978; 62: 884-887.
10. Durak I, Isik ACÜ, Canbolat O, Akyol Ö, Kavutcu M. Adenosine deaminase, 5′ nucleotidase, xanthine oxidase, Superoxide dismutase, and catalase activities in cancerous and noncancerous human laryngeal tissues. Free Rad Biol Med 1993; 15: 681-684.
11. Franco R, Canela E I, Bozal J. Heterogenous localization of some purine enzymes in subcellular fractions of rat brain and cerebellum. Neurochem Res 1986; 11: 423-435.
12. Franco R, Casado V, Ciruela F, Saura C, Mallol J, Canela EI, Lluis C. Cell surface adenosine deaminase: much more than an ectoenzyme. Prog Neurobiol 1997; 52: 283-294.
13. Giusti G, Galanti B. Adenosine deaminase: colorimetric method In: Bergmeyer UH, ed. Methods of enzymatic analysis. Weinheim, Verlag Chemie, 1984: 315-323.
14. Kameoka J, Tanaka T, Nojima Y, Schlossman SF, Morimoto M. Direct association of adenosine deaminase with a T cell activation antigen CD26. Science 1993; 261: 466-469.
15. Lambeir AM, Diaz Pereira JF, Chacon P, Vermeulen G, Heremans K, Devreese B, van Beeumen J et al. A prediction of DPP IV/CD26 domain structure from a physico-chemical investigation of dipeptidyl peptidase IV (CD26) from human seminal plasma. Biochim Biophys Acta 1997; 1340: 215-226.
16. Lowry O, Rosenbraugh N, Farr L, Rondall R. Protein measurement with the folin phenol reagent. J Biol Chem 1951; 183: 265-275.
17. Morrison ME, Vijayasaradhi S, Engelstein D, Albino AP, Houghton AH. A marker for neoplastic progression of human melanocytes is a cell surface ectopeptidase. J Exp Med 1993; 177: 1135-1143.
18. Nagatsu T, Hino M, Fuyamada H, Hayakawa T, Sakibara S, Nakagawa Y, Takemoto T. New chromogenic substrates for x-prolyl dipeptidyl-aminopeptidase. Anal Biochem 1976; 74: 466-476.
19. Nagy JI, Yamamato T, Uemura H, Schrader WP. Adenosine deaminase in rodent median eminence: detection by antibody to the mouse enzyme and co-localization with adenosinedeaminase-complexing protein (CD26). Neuroscience 1996; 73: 459-471.
20. Schrader WP, West CA. Localization of adenosine deaminase and adenosine deaminase complexing protein in rabbit heart. Implications for adenosine metabolism. Circ Res 1990; 66: 754-762.
21. Schrader WP, West CA, Rudofsky UH, Samsonoff WA. Subcellular distribution of adenosine deaminase and adenosine deaminase-complexing protein in rabbit kidney: implications for adenosine metabolism. J Histochem Cytochem 1994; 42: 775-782.
22. Schroder FH, Hermanek P, Denis L, Fair WR, Gospodarowicz MK, Pavone-Macaluso M. The TNM classification of prostate cancer. Prostate Suppl 1992; 4: 129-138.
23. Ten Kate J, van den Ingh HF, Khan PM. Adenosine deaminase complexing protein (ADCP) immunoreactivity in colorectal adenocarcinoma. Int J Cancer 1986; 15: 479-485.
24. Tritsch GL, Murphy GP. Adenosine deaminase specific activity in normal, benign hypertrophied and neoplastic human prostate tissue. Eur Urol 1980; 6: 229-231.
25. Van den Oord JJ. Expression of CD26/dipeptidyl-peptidase IV in benign and malignant pigment-cell lesions of the skin. Br J Dermatol 1998; 138: 615-621.
26. Vanhoof G, De Meester I, van Sande M, Sharpe S, Yaron A. Distribution of proline-specific aminopeptidases in human tissues and body fluids. Eur J Clin Chem Clin Biochem 1992; 30: 333-338.